Filing Details
- Accession Number:
- 0001250853-14-000068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-09 20:44:04
- Reporting Period:
- 2014-01-23
- Filing Date:
- 2014-04-09
- Accepted Time:
- 2014-04-09 20:44:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1390478 | Galena Biopharma Inc. | GALE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197482 | A Steven Kriegsman | C/O Galena Biopharma, Inc. 4640 S.w. Macadam Avenue, Suite 270 Portland OR 97239 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-23 | 100,000 | $1.18 | 105,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-23 | 50,000 | $2.31 | 155,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-23 | 150,000 | $5.92 | 5,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-01-23 | 100,000 | $0.00 | 100,000 | $1.18 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-01-23 | 50,000 | $0.00 | 50,000 | $2.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-24 | No | 4 | M | Direct | |
| 0 | 2021-01-13 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.8845 to $5.9722 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option vested in equal quarterly installments of 25,000 shares on each of June 25, 2011, September 25, 2011, December 25, 2011 and March 25, 2012.
- The option vested in equal quarterly installments of 12,500 shares on each of March 31, 2011, June 30, 2011, September 30, 2011 and December 31, 2011.
Billionaire Hedge Funds
